NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its distribution agreement with GeneKor Medical has been expanded to include Romania and Turkey.

GeneKor now has the exclusive sales and marketing rights to Rosetta Genomics' microRNA-based cancer testing services in Romania, and non-exclusive rights in Turkey. The companies originally inked a distribution deal covering Greece in 2010.

Financial and other terms of today's deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.